BMS-582949
BMS-582949 (compound 7k) is an orally active and highly selective p38α MAP kinase inhibitor, with IC50 values of 13 nM for p38α, and 50 nM for cellular TNFα. BMS-582949 can be used for research on rheumatoid arthritis[1].
Product Specifications
CAS Number
[623152-17-0]
UNSPSC
12352005
Hazard Statement
H360-H373
Target
P38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bms-582949.html
Solubility
10 mM in DMSO
Smiles
O=C(NCCC)C1=CN(N=CN=C2NC3=CC(C(NC4CC4)=O)=CC=C3C)C2=C1C
Molecular Formula
C22H26N6O2
Molecular Weight
406.48
Precautions
P260-P280-P405-P501
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14305/BMS-582949-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14305/
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
P38α
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Corynebacterium efficiens Putative sporulation transcription regulator WhiA (whiA)
Recombinant Corynebacterium efficiens Putative sporulation transcription regulator WhiA (whiA)
Recombinant Corynebacterium efficiens Putative sporulation transcription regulator WhiA (whiA)
Recombinant Corynebacterium efficiens Putative sporulation transcription regulator WhiA (whiA)
Recombinant Corynebacterium efficiens Putative sporulation transcription regulator WhiA (whiA)
